• Profile
Close

Health-related quality of life after diagnosis and treatment of differentiated thyroid cancer

JAMA Otolaryngology—Head & Neck Surgery Jan 23, 2019

Nickel B, et al. - Authors assessed 1,005 subjects (aged 18 to 79 years) from the major postsurgical thyroid cancer treatment center and the population-based Cancer Registry in Queensland, Australia, to evaluate health-related quality of life (HRQOL) following diagnosis and treatment of differentiated thyroid cancer (DTC) and how it is impacted by the type of surgical treatment received. About 88.6% of participants were diagnosed with papillary thyroid cancer; 56.4% of them were identified with tumors less than 2 cm in size and received a total thyroidectomy. They observed subjects diagnosed with DTC had wide-range of HRQOL issues, including physical (66.0%), lifestyle (8.2%) and psychological (18.6%) issues. Candidates with hemithyroidectomy were noted with negligible unfavorable consequences and better HRQOL results vs those who had a total thyroidectomy.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay